🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSurvodutide (GCG/GLP-1) — anyone have experience? Page 4

Survodutide (GCG/GLP-1) — anyone have experience?

stefan_berlin Sat, Mar 28, 2026 at 5:44 AM 16 replies 838 viewsPage 4 of 4
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Apr 4, 2026 at 9:25 PM#16
Dr.PulmRoch said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

This matches mine closely enough to be worth saying so out loud.

44 19LondonLisa, mike_nyc, VendorMark and 41 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Apr 5, 2026 at 5:58 PM#17

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Ask again with the specifics and you will get a better answer than this one.

43 18alex_tucson, kevin_tulsa, Dr.PainCLE and 40 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Apr 6, 2026 at 2:31 PM#18
PharmHunterJen said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Same experience, arrived at from the opposite direction.

42 17Dr.Martinez, mike_mod, SarahChen_PharmD and 39 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Apr 7, 2026 at 11:03 AM#19
PharmHunterJen said:
If two explanations both fit, the useful question is which one predicts something the other does not.

Adding the part of the answer the thread has not reached. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Apr 7, 2026 at 1:03 PM
41 16ben_calgary, patPC_UT, Dr.DermMIA and 38 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 8, 2026 at 7:35 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Tagging this one for the weekly digest.

19 19PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 16 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register